VEON shares recently moved above their 200-day moving average, signaling a potential shift in trend that attracted renewed investor attention. Trading volume on that day exceeded the stock’s ten-day average by roughly 40%, reflecting heightened market interest. On the analyst front, four firms have weighed in over the past month: one with a Strong Buy call, one with a Buy call and two with Hold calls. The consensus rating stands at Moderate Buy, with a median price objective implying double-digit upside from current levels.

In its most recent quarter, VEON reported earnings per share slightly below consensus estimates while delivering revenue marginally ahead of forecasts. The company generated a return on equity of 58.7% and a net margin of 15.3%, underscoring strong profitability on its emerging-market operations. On the balance sheet, VEON carries a debt-to-equity ratio of 2.45 and maintains current and quick ratios just under parity. In mid-November, the board authorized a new share repurchase program, signaling management’s view that the stock remains undervalued and reinforcing capital return priorities.

VEON has entered into a multi-year partnership with MindBridge, a leader in AI-powered financial intelligence, to deploy an enterprise-wide analytics platform. The initiative will standardize and automate the review of all financial transactions across VEON’s global footprint, improving internal controls and audit efficiency. Management expects the AI-driven solution to reduce manual testing time by over 50%, strengthen compliance frameworks and lay the groundwork for offering analytics services to external clients and government entities.

VEON’s principal shareholder unit in Amsterdam is leading a public offering of 12.5 million Kyivstar common shares, with underwriters granted an option to sell an additional 1.9 million shares. The transaction is scheduled to close in early February and is managed by Morgan Stanley, Barclays, Cantor Fitzgerald and Rothschild & Co, with co-managers including Benchmark, StoneX and Northland Capital Markets. Proceeds from the sale will provide VEON with enhanced financial flexibility while reducing its direct stake in Kyivstar’s Ukrainian operations.